Annual CFF
$6.90 M
-$183.83 M-96.38%
December 31, 2023
Summary
- As of February 7, 2025, SPRY annual cash flow from financing activities is $6.90 million, with the most recent change of -$183.83 million (-96.38%) on December 31, 2023.
- During the last 3 years, SPRY annual CFF has risen by +$1.80 million (+35.30%).
- SPRY annual CFF is now -96.38% below its all-time high of $190.73 million, reached on December 31, 2022.
Performance
SPRY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$680.00 K
+$135.00 K+24.77%
September 30, 2024
Summary
- As of February 7, 2025, SPRY quarterly cash flow from financing activities is $680.00 thousand, with the most recent change of +$135.00 thousand (+24.77%) on September 30, 2024.
- Over the past year, SPRY quarterly CFF has increased by +$135.00 thousand (+24.77%).
- SPRY quarterly CFF is now -99.65% below its all-time high of $193.82 million, reached on December 31, 2022.
Performance
SPRY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.29 M
-$241.00 K-6.83%
September 30, 2024
Summary
- As of February 7, 2025, SPRY TTM cash flow from financing activities is $3.29 million, with the most recent change of -$241.00 thousand (-6.83%) on September 30, 2024.
- Over the past year, SPRY TTM CFF has dropped by -$241.00 thousand (-6.83%).
- SPRY TTM CFF is now -98.35% below its all-time high of $198.91 million, reached on September 30, 2023.
Performance
SPRY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SPRY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.4% | +24.8% | -6.8% |
| 3 y3 years | +35.3% | +24.8% | -6.8% |
| 5 y5 years | +35.3% | +24.8% | -6.8% |
SPRY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.4% | at low | -99.7% | +143.7% | -98.3% | +206.5% |
| 5 y | 5-year | -96.4% | +35.3% | -99.7% | +143.7% | -98.3% | +206.5% |
| alltime | all time | -96.4% | +35.3% | -99.7% | +143.7% | -98.3% | +206.5% |
ARS Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $680.00 K(+24.8%) | $3.29 M(-6.8%) |
| Jun 2024 | - | $545.00 K(+111.2%) | $3.53 M(-39.6%) |
| Mar 2024 | - | $258.00 K(-85.7%) | $5.84 M(-15.4%) |
| Dec 2023 | $6.90 M | $1.80 M(+96.0%) | $6.90 M(-96.5%) |
| Sep 2023 | - | $921.00 K(-67.7%) | $198.91 M(+1.3%) |
| Jun 2023 | - | $2.85 M(+116.4%) | $196.44 M(+1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $1.32 M(-99.3%) | $192.96 M(+1.2%) |
| Dec 2022 | $190.73 M(+258.8%) | $193.82 M(<-9900.0%) | $190.73 M(-6278.6%) |
| Sep 2022 | - | -$1.56 M(+149.8%) | -$3.09 M(+101.6%) |
| Jun 2022 | - | -$623.00 K(-31.4%) | -$1.53 M(+68.6%) |
| Mar 2022 | - | -$908.00 K | -$908.00 K |
| Dec 2021 | $53.16 M(+942.5%) | - | - |
| Dec 2020 | $5.10 M | - | - |
FAQ
- What is ARS Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals annual CFF year-on-year change?
- What is ARS Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals quarterly CFF year-on-year change?
- What is ARS Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for ARS Pharmaceuticals?
- What is ARS Pharmaceuticals TTM CFF year-on-year change?
What is ARS Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of SPRY is $6.90 M
What is the all time high annual CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high annual cash flow from financing activities is $190.73 M
What is ARS Pharmaceuticals annual CFF year-on-year change?
Over the past year, SPRY annual cash flow from financing activities has changed by -$183.83 M (-96.38%)
What is ARS Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of SPRY is $680.00 K
What is the all time high quarterly CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high quarterly cash flow from financing activities is $193.82 M
What is ARS Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, SPRY quarterly cash flow from financing activities has changed by +$135.00 K (+24.77%)
What is ARS Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of SPRY is $3.29 M
What is the all time high TTM CFF for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high TTM cash flow from financing activities is $198.91 M
What is ARS Pharmaceuticals TTM CFF year-on-year change?
Over the past year, SPRY TTM cash flow from financing activities has changed by -$241.00 K (-6.83%)